Hua Sui

4.4k total citations
89 papers, 3.0k citations indexed

About

Hua Sui is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hua Sui has authored 89 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 23 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Hua Sui's work include Cancer-related molecular mechanisms research (10 papers), Alzheimer's disease research and treatments (9 papers) and Epigenetics and DNA Methylation (8 papers). Hua Sui is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Alzheimer's disease research and treatments (9 papers) and Epigenetics and DNA Methylation (8 papers). Hua Sui collaborates with scholars based in China, United States and Sweden. Hua Sui's co-authors include Lihong Zhou, Qing Ji, Qi Li, Qi Li, Libin Zhan, Wanli Deng, Qin Li, Yuanyuan Feng, Jianfeng Cai and Xuan Liu and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Hua Sui

86 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hua Sui China 32 1.8k 862 690 326 222 89 3.0k
Ming‐Ju Hsieh Taiwan 32 1.9k 1.0× 689 0.8× 430 0.6× 232 0.7× 231 1.0× 140 3.0k
Chin‐Wen Chi Taiwan 38 2.0k 1.1× 841 1.0× 559 0.8× 381 1.2× 179 0.8× 77 3.7k
Laura García‐Bermejo Spain 33 1.8k 1.0× 786 0.9× 463 0.7× 310 1.0× 81 0.4× 88 3.3k
Chi Hin Cho China 28 1.2k 0.7× 486 0.6× 593 0.9× 315 1.0× 212 1.0× 54 2.4k
Chul‐Ho Jeong South Korea 26 1.2k 0.7× 502 0.6× 323 0.5× 153 0.5× 191 0.9× 69 2.4k
Do Kyung Kim South Korea 31 1.6k 0.9× 413 0.5× 377 0.5× 139 0.4× 182 0.8× 136 2.9k
Yifeng Zheng China 28 1.2k 0.7× 447 0.5× 742 1.1× 577 1.8× 261 1.2× 72 2.7k
Liang Sheng China 29 969 0.5× 422 0.5× 753 1.1× 176 0.5× 135 0.6× 57 2.2k
Yuewen Gong Canada 33 1.5k 0.8× 393 0.5× 367 0.5× 316 1.0× 251 1.1× 127 3.1k

Countries citing papers authored by Hua Sui

Since Specialization
Citations

This map shows the geographic impact of Hua Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Sui more than expected).

Fields of papers citing papers by Hua Sui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Sui. The network helps show where Hua Sui may publish in the future.

Co-authorship network of co-authors of Hua Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Sui. A scholar is included among the top collaborators of Hua Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Sui. Hua Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Bing, Qian Chen, Ting Wang, et al.. (2025). Sodium butyrate inhibits colorectal cancer development by reducing M2 macrophage polarization and PD-L1 expression. mSystems. 10(12). e0069225–e0069225.
2.
Zhou, Hongyan, Q. Luo, Hua Sui, et al.. (2023). Recent advances in the involvement of epigenetics in the pathogenesis of systemic lupus erythematosus. Clinical Immunology. 258. 109857–109857. 9 indexed citations
3.
Sui, Hua, Wanli Deng, Bing Han, et al.. (2023). YTE-17 inhibits colonic carcinogenesis by resetting antitumor immune response via Wnt5a/JNK mediated metabolic signaling. Journal of Pharmaceutical Analysis. 14(4). 100901–100901. 9 indexed citations
4.
Zhang, Yuli, Ni Chai, Zhenzhen Wei, et al.. (2022). YYFZBJS inhibits colorectal tumorigenesis by enhancing Tregs-induced immunosuppression through HIF-1α mediated hypoxia in vivo and in vitro. Phytomedicine. 98. 153917–153917. 31 indexed citations
5.
Zhou, Hongyan, Hua Sui, Nan Yang, et al.. (2021). The Impact of Inflammatory Immune Reactions of the Vascular Niche on Organ Fibrosis. Frontiers in Pharmacology. 12. 750509–750509. 10 indexed citations
6.
Song, Qing, Zhifen Han, Xinnan Wu, et al.. (2021). β-Arrestin1 Promotes Colorectal Cancer Metastasis Through GSK-3β/β-Catenin Signaling- Mediated Epithelial-to-Mesenchymal Transition. Frontiers in Cell and Developmental Biology. 9. 650067–650067. 11 indexed citations
7.
Bi, Tingting, Libin Zhan, Wen Zhou, & Hua Sui. (2020). Effect of the ZiBuPiYin Recipe on Diabetes-Associated Cognitive Decline in Zucker Diabetic Fatty Rats After Chronic Psychological Stress. Frontiers in Psychiatry. 11. 272–272. 20 indexed citations
8.
Song, Qing, Liu Yang, Zhifen Han, et al.. (2020). Tanshinone IIA Inhibits Epithelial-to-Mesenchymal Transition Through Hindering β-Arrestin1 Mediated β-Catenin Signaling Pathway in Colorectal Cancer. Frontiers in Pharmacology. 11. 586616–586616. 14 indexed citations
9.
Wu, Xinnan, Ruixiao Li, Qing Song, et al.. (2019). JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 435–435. 57 indexed citations
10.
Xia, Shilin, Qi Zhou, Han Liu, et al.. (2019). Emodin Attenuates Severe Acute Pancreatitis via Antioxidant and Anti-inflammatory Activity. Inflammation. 42(6). 2129–2138. 68 indexed citations
11.
Sui, Hua, Xuan Liu, Jinhua Zhang, et al.. (2017). Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancer. Oncology Reports. 38(4). 2087–2095. 16 indexed citations
12.
13.
Sui, Hua, Lihong Zhou, Yali Zhang, et al.. (2015). Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF‐κB Pathway in Colorectal Cancer. Journal of Cellular Biochemistry. 117(6). 1471–1481. 55 indexed citations
14.
15.
Sui, Hua, et al.. (2014). miR200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer. Molecular Cancer Therapeutics. 13(12). 3137–3151. 73 indexed citations
16.
Ji, Qing, Lihong Zhou, Ziduan Han, et al.. (2014). Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. British Journal of Cancer. 111(4). 736–748. 311 indexed citations
17.
Deng, Wanli, Hua Sui, Qiaolin Wang, et al.. (2013). A Chinese herbal formula, Yi-Qi-Fu-Sheng, inhibits migration/invasion of colorectal cancer by down-regulating MMP-2/9 via inhibiting the activation of ERK/MAPK signaling pathways. BMC Complementary and Alternative Medicine. 13(1). 65–65. 42 indexed citations
18.
Sui, Hua, et al.. (2012). Lipopolysaccharide and dose of nicotine determine the effects of nicotine on murine bone marrow-derived dendritic cells. Molecular Medicine Reports. 5(4). 1005–1010. 19 indexed citations
19.
Jin, Hao, Hua Sui, Yi Nan Wang, & Feng Gao. (2012). Nicotine Up-regulated 4-1BBL Expression by Activating Mek-PI3K Pathway Augments the Efficacy of Bone Marrow-Derived Dendritic Cell Vaccination. Journal of Clinical Immunology. 33(1). 246–254. 12 indexed citations
20.
Shi, Xiang, Libin Zhan, Li Liu, et al.. (2011). Rat hippocampal proteomic alterations following intrahippocampal injection of amyloid beta peptide (1–40). Neuroscience Letters. 500(2). 87–91. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming‐Ju Hsieh Breakdown of academic impact, for papers by Chin‐Wen Chi Breakdown of academic impact, for papers by Laura García‐Bermejo Breakdown of academic impact, for papers by Chi Hin Cho Breakdown of academic impact, for papers by Chul‐Ho Jeong Breakdown of academic impact, for papers by Do Kyung Kim Breakdown of academic impact, for papers by Yifeng Zheng Breakdown of academic impact, for papers by Liang Sheng Breakdown of academic impact, for papers by Yuewen Gong
Rankless by CCL
2026